Zdrowie i gospodarka · 30/05/2019

FDA Clears LUPRON Injection for Sale, Citing Lack of Safety or Effectiveness Concerns

The US Food and Drug Administration (FDA) has announced that it will not withdraw approval of LUPRON (Leuprolide Acetate) injection, 1mg/0.2mL, due to concerns over safety or effectiveness, allowing the drug to remain on the market.